-Economic and Political Weekly The key to improving the quality of healthcare services in India and reducing costs at the same time can be found by enacting legislation which lays down minimum standards of patient care. In the absence of such standards and the reluctance of health insurance companies to standardise either price or quality, healthcare services continue to be expensive and of doubtful quality. Developing standards of patient care by...

-The Telegraph New Delhi: The Narendra Modi government may introduce a health cess to fund free health care services and launch seven preventive campaigns to curb illnesses under a draft health policy unveiled today. Some analysts, however, said the draft of the National Health Policy 2015 lacked emphasis on regulating India's private health industry, necessary to curb the high cost of health care. The draft says the government has the "political will" to...

-The Hindu New Delhi: While observing that the Court could not encroach into policy matters of the government, the Delhi High Court has dismissed a public interest writ petition seeking directions to the Centre to make available generic medicines and medical treatment to the public at large at a reasonable cost. A Division Bench comprising Chief Justice G. Rohini and Justice R.S. Endlaw had earlier this week said that the Centre and...

-The Times of India NEW DELHI: The government's price control measure for essential medicines has had an unexpected fallout - several of these drugs, including those for treatment of chronic ailments such as high uric acid levels, diabetes and acne, are either in short supply or have gone missing from chemist shops. Among the drugs facing shortage are Zyloric (prescribed for uric acid control), Ocid (acidity), CCM (calcium supplement) and Etroxin (a...

-Business Standard This would be in addition to 348 drugs already under price ceiling The National Pharmaceutical Pricing Authority (NPPA) has capped the prices of another 52 essential drugs, in a move that could impact drug manufacturers Lupin, Cadila Healthcare and Merck. This is in addition to the 348 drugs already under a price ceiling. The majority of the 52 new drugs are antibiotics, painkillers and medicines used for treating cancer and skin...